These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22944305)
1. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution. Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305 [TBL] [Abstract][Full Text] [Related]
2. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization. Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813 [TBL] [Abstract][Full Text] [Related]
3. Development of 2-hydroxymethyl-3,5,6-trimethylpyrazine palmitate-loaded lipid emulsion: formulation, optimization, characterization, pharmacokinetics, biodistribution and pharmacodynamics. Cao R; Li Q; Li H; Chu T; Jin H; Mao SJ J Drug Target; 2013 May; 21(4):341-53. PubMed ID: 23311747 [TBL] [Abstract][Full Text] [Related]
4. Optimization, and Geng D; Li Y; Wang C; Ren B; Wang H; Wu C; Zhang Y; Zhao L; Zhao L Drug Deliv; 2021 Dec; 28(1):873-883. PubMed ID: 33960250 [TBL] [Abstract][Full Text] [Related]
5. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection]. Tian LL; Tang X; He HB; Wang J Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242 [TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting. Jang JH; Kim CK; Choi HG; Sung JH Drug Dev Ind Pharm; 2009 Mar; 35(3):363-8. PubMed ID: 19016100 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan. Yu C; Gu P; Zhang W; Cai C; He H; Tang X Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542 [TBL] [Abstract][Full Text] [Related]
8. Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion. Marín-Quintero D; Fernández-Campos F; Calpena-Campmany AC; Montes-López MJ; Clares-Naveros B; Del Pozo-Carrascosa A J Pharm Sci; 2013 Nov; 102(11):4015-23. PubMed ID: 23970386 [TBL] [Abstract][Full Text] [Related]
9. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics. Zhang HY; Tang X; Li HY; Liu XL Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191 [TBL] [Abstract][Full Text] [Related]
10. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics. Cai W; Deng W; Yang H; Chen X; Jin F Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221 [TBL] [Abstract][Full Text] [Related]
11. Formulation of a stable and high-loaded quercetin injectable emulsion. Sun H; Xu H; Yang X; Li N; Liu Z; Pan W; Yuan Y Pharm Dev Technol; 2011; 16(6):609-15. PubMed ID: 20718691 [TBL] [Abstract][Full Text] [Related]
12. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol. Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside. Zhang X; Lü S; Han J; Sun S; Wang L; Li Y Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077 [TBL] [Abstract][Full Text] [Related]
14. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres. Wang YJ; Wang J; Zhang HY; He HB; Tang X J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337 [TBL] [Abstract][Full Text] [Related]
15. [Optimization of ligustrazine phosphate thermosensitive gel formulation by central composite design-response surface methodology]. Meng DM; Xu YH; Ding PT; Deng YJ; Wei MY Zhong Yao Cai; 2008 Feb; 31(2):286-8. PubMed ID: 18619280 [TBL] [Abstract][Full Text] [Related]
16. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex. Xia XJ; Guo RF; Liu YL; Zhang PX; Zhou CP; Jin DJ; Wang RY Chem Pharm Bull (Tokyo); 2011; 59(3):321-6. PubMed ID: 21372412 [TBL] [Abstract][Full Text] [Related]
17. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. Lu Y; Zhang Y; Yang Z; Tang X Int J Pharm; 2009 Jan; 366(1-2):160-9. PubMed ID: 18835427 [TBL] [Abstract][Full Text] [Related]
18. Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy. Ma WC; Zhang Q; Li H; Larregieu CA; Zhang N; Chu T; Jin H; Mao SJ Int J Pharm; 2013 Jun; 450(1-2):21-30. PubMed ID: 23608202 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. Li G; Fan Y; Li X; Wang X; Li Y; Liu Y; Li M Int J Pharm; 2012 Apr; 425(1-2):53-61. PubMed ID: 22266535 [TBL] [Abstract][Full Text] [Related]
20. Optimization of tocol emulsions for the intravenous delivery of clarithromycin. Li J; Nie S; Yang X; Wang C; Cui S; Pan W Int J Pharm; 2008 May; 356(1-2):282-90. PubMed ID: 18289806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]